Sanchís-Gomar, FabiánLippi, GiuseppeLucía Mulas, Alejandro2016-05-192016-05-192016Sanchis-Gomar, F., Lippi, G., & Lucia, A. (2016). ‘Mitotherapy’ for heart failure. Trends in molecular medicine, 22(4), 267-269.147149141471499Xhttp://hdl.handle.net/11268/5149Abnormalities in mitochondrial dynamics along with those for the molecular mediators involved are presently being viewed with increased interest in the field of cardiovascular disease. Recent research highlights OPA1, a dynamin-like GTPase mediating mitochondrial fusion, as well as the 'mitoproteases' OMA1 and YME1L, as potential therapeutic targets against heart failure.eng‘Mitotherapy’ for heart failurejournal article10.1016/j.molmed.2016.02.007restricted accessCorazónEnvejecimientoEnfermedad cardiovascularEnvejecimiento